{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:56:24Z","timestamp":1790934984495,"version":"4.1.0"},"reference-count":56,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Ptosis is a common ocular complaint in the elderly population. While most cases are often due to involutional changes in the eyelid, neurogenic, mechanical or myogenic diseases should remain as important differential diagnoses. We report a case of a 75-year-old Chinese man who presented with chronic progressive ptosis and was initially managed as presumed seronegative ocular myasthenia gravis (MG). Despite positive bedside findings suggestive of MG, serological and electrophysiological investigations were inconclusive, and there was no clinical response to pyridostigmine. The diagnosis was achieved only after an opportunistic frontalis muscle biopsy obtained during planned brow lift surgery demonstrated histopathological features supportive of a mitochondrial aetiology. This case highlights the diagnostic challenge of distinguishing mitochondrial myopathies (MM) from ocular MG, emphasises clinical features that should prompt reconsideration of the diagnosis, and illustrates how opportunistic biopsy during oculoplastic surgery may facilitate diagnosis in selected patients with persistent diagnostic uncertainty.<\/jats:p>","DOI":"10.3390\/jcm15197646","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:10:48Z","timestamp":1790932248000},"page":"7646","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mitochondrial Myopathy in the Oculoplastic Practice"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2834-1192","authenticated-orcid":false,"given":"Alex J. Y.","family":"Cheong","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, National University Health System, Singapore 119228, Singapore"},{"name":"Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119077, Singapore"},{"name":"Department of Ophthalmology, Ng Teng Fong General Hospital, Singapore 609606, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbin","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National University Health System, Singapore 119228, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi Wei","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National University Health System, Singapore 119228, Singapore"},{"name":"Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119077, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, National University Health System, Singapore 119077, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kong Bing","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Pathology, National University Health System, Singapore 119077, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryanne Chew","family":"Romero","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National University Health System, Singapore 119228, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanche X. H.","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National University Health System, Singapore 119228, Singapore"},{"name":"Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119077, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/01676830.2013.788673","article-title":"Relative incidence of blepharoptosis subtypes in an oculoplastics practice at a tertiary care center","volume":"32","author":"Lim","year":"2013","journal-title":"Orbit"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0037-1598188","article-title":"Clinical Evaluation of Blepharoptosis: Distinguishing Age-Related Ptosis from Masquerade Conditions","volume":"31","author":"Latting","year":"2017","journal-title":"Semin. Plast. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ana.410370106","article-title":"Late-onset mitochondrial myopathy","volume":"37","author":"Johnston","year":"1995","journal-title":"Ann. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e00304","DOI":"10.1016\/j.neurot.2023.11.001","article-title":"A clinical approach to diagnosis and management of mitochondrial myopathies","volume":"21","author":"Chin","year":"2024","journal-title":"Neurotherapeutics"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Vinciguerra, C., Bevilacqua, L., Lupica, A., Ginanneschi, F., Piscosquito, G., Rini, N., Rossi, A., Barone, P., Brighina, F., and Di Stefano, V. (2023). Diagnosis and Management of Seronegative Myasthenia Gravis: Lights and Shadows. Brain Sci., 13.","DOI":"10.3390\/brainsci13091286"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Evoli, A., and Iorio, R. (2020). Controversies in Ocular Myasthenia Gravis. Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.605902"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jns.2007.02.020","article-title":"A prospective study assessing the utility of Cogan\u2019s lid twitch sign in patients with isolated unilateral or bilateral ptosis","volume":"256","author":"Bhatt","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.clinph.2013.11.005","article-title":"Reliability of SFEMG in diagnosing myasthenia gravis: Sensitivity and specificity calculated on 100 prospective cases","volume":"125","author":"Padua","year":"2014","journal-title":"Clin. Neurophysiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1212\/CPJ.0000000000000795","article-title":"Neuromuscular Junction Abnormalities in Mitochondrial Disease: An Observational Cohort Study","volume":"11","author":"Braz","year":"2021","journal-title":"Neurol. Clin. Pract."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/gim.2014.177","article-title":"Diagnosis and management of mitochondrial disease: A consensus statement from the Mitochondrial Medicine Society","volume":"17","author":"Parikh","year":"2015","journal-title":"Genet. Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Phadke, R. (2017). Myopathology of Adult and Paediatric Mitochondrial Diseases. J. Clin. Med., 6.","DOI":"10.3390\/jcm6070064"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1086\/507132","article-title":"Mitochondrial DNA-deletion mutations accumulate intracellularly to detrimental levels in aged human skeletal muscle fibers","volume":"79","author":"Bua","year":"2006","journal-title":"Am. J. Hum. Genet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41379-018-0164-x","article-title":"A pattern-based approach to the interpretation of skeletal muscle biopsies","volume":"32","author":"Cai","year":"2019","journal-title":"Mod. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/joim.13054","article-title":"Mitochondrial disease in children","volume":"287","author":"Rahman","year":"2020","journal-title":"J. Intern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Bottoni, P., Gionta, G., and Scatena, R. (2022). Remarks on Mitochondrial Myopathies. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010124"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.24362","article-title":"Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease","volume":"77","author":"Gorman","year":"2015","journal-title":"Ann. Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.12998\/wjcc.v7.i9.1066","article-title":"Adult-onset mitochondrial encephalopathy in association with the MT-ND3 T10158C mutation exhibits unique characteristics: A case report","volume":"7","author":"Fu","year":"2019","journal-title":"World J. Clin. Cases"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/brain\/109.5.915","article-title":"The clinical features of mitochondrial myopathy","volume":"109","author":"Petty","year":"1986","journal-title":"Brain"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11910-002-0067-5","article-title":"Chronic progressive external ophthalmoplegia","volume":"2","author":"Lee","year":"2002","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.survophthal.2009.10.002","article-title":"The neuro-ophthalmology of mitochondrial disease","volume":"55","author":"Fraser","year":"2010","journal-title":"Surv. Ophthalmol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/B978-0-12-821751-1.00018-X","article-title":"Progressive external ophthalmoplegia","volume":"194","author":"Hirano","year":"2023","journal-title":"Handb. Clin. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1001\/archneur.1968.00470360076008","article-title":"Ophthalmoplegia plus. The neurodegenerative disorders associated with progressive external ophthalmoplegia","volume":"18","author":"Drachman","year":"1968","journal-title":"Arch. Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Lee, E., Ozigbo, A.A., Varon, J., Halma, M., Laezzo, M., Ang, S.P., and Iglesias, J. (2025). Mitochondrial Reactive Oxygen Species: A Unifying Mechanism in Long COVID and Spike Protein-Associated Injury: A Narrative Review. Biomolecules, 15.","DOI":"10.3390\/biom15091339"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"103766","DOI":"10.1016\/j.redox.2025.103766","article-title":"Viral mitochondriopathy in COVID-19","volume":"85","author":"Chen","year":"2025","journal-title":"Redox Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/clpt.2014.64","article-title":"Antiretroviral therapy-induced mitochondrial toxicity: Potential mechanisms beyond polymerase-\u03b3 inhibition","volume":"96","author":"Selvaraj","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_26","unstructured":"Adam, M.P., Bick, S., Mirzaa, G.M., Wallace, E.S., and Amemiya, A. (2020). Oculopharyngeal Muscular Dystrophy. GeneReviews(\u00ae), University of Washington."},{"key":"ref_27","first-page":"1","article-title":"Clinical and molecular aspects of the myotonic dystrophies: A review","volume":"32","author":"Brook","year":"2005","journal-title":"Muscle Nerve"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/08820530701745181","article-title":"Congenital fibrosis of the extraocular muscles","volume":"23","author":"Heidary","year":"2008","journal-title":"Semin. Ophthalmol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/muscles2010007","article-title":"Diagnostic Testing in Suspected Primary Mitochondrial Myopathy","volume":"2","author":"Hinojosa","year":"2023","journal-title":"Muscles"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/S0960-8966(97)00085-0","article-title":"Morphological changes in muscle fibers in oculopharyngeal muscular dystrophy","volume":"7","author":"Chateau","year":"1997","journal-title":"Neuromuscul. Disord."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/mus.23535","article-title":"Muscle phenotype in patients with myotonic dystrophy type 1","volume":"47","author":"Andersen","year":"2013","journal-title":"Muscle Nerve"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e730","DOI":"10.1212\/WNL.0000000000200745","article-title":"Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis","volume":"99","author":"Davis","year":"2022","journal-title":"Neurology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1056\/NEJMoa2314761","article-title":"Genome Sequencing for Diagnosing Rare Diseases","volume":"390","author":"Wojcik","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Gervasoni, J., Primiano, A., Marini, F., Sabino, A., Biancolillo, A., Calvani, R., Picca, A., Marzetti, E., Persichilli, S., and Urbani, A. (2020). Fourier-Transform Infrared Spectroscopy of Skeletal Muscle Tissue: Expanding Biomarkers in Primary Mitochondrial Myopathies. Genes, 11.","DOI":"10.3390\/genes11121522"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.mito.2008.05.003","article-title":"Neuroimaging of mitochondrial disease","volume":"8","author":"Saneto","year":"2008","journal-title":"Mitochondrion"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s41687-022-00534-y","article-title":"Psychometric performance of the Primary Mitochondrial Myopathy Symptom Assessment (PMMSA) in a randomized, double-blind, placebo-controlled crossover study in subjects with mitochondrial disease","volume":"6","author":"Gwaltney","year":"2022","journal-title":"J. Patient Rep. Outcomes"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1212\/01.wnl.0000219759.72195.41","article-title":"Mitochondrial disease in adults: A scale to monitor progression and treatment","volume":"66","author":"Schaefer","year":"2006","journal-title":"Neurology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10545-016-9948-7","article-title":"International Paediatric Mitochondrial Disease Scale","volume":"39","author":"Koene","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_39","first-page":"1380","article-title":"Patient care standards for primary mitochondrial disease: A consensus statement from the Mitochondrial Medicine Society","volume":"19","author":"Parikh","year":"2017","journal-title":"Genet Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/MOP.0000000000000954","article-title":"Mitochondrial medicine therapies: Rationale, evidence, and dosing guidelines","volume":"32","author":"Barcelos","year":"2020","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2326409817707771","DOI":"10.1177\/2326409817707771","article-title":"Coenzyme Q10 in the Treatment of Mitochondrial Disease","volume":"5","author":"Neergheen","year":"2017","journal-title":"J. Inborn Errors Metab. Screen."},{"key":"ref_42","first-page":"212","article-title":"Coenzyme Q10 treatment in mitochondrial encephalomyopathies. Short-term double-blind, crossover study","volume":"37","author":"Chen","year":"1997","journal-title":"Eur. Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/mus.21758","article-title":"A randomized trial of coenzyme Q10 in mitochondrial disorders","volume":"42","author":"Glover","year":"2010","journal-title":"Muscle Nerve"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Mantle, D., Lopez-Lluch, G., and Hargreaves, I.P. (2023). Coenzyme Q10 Metabolism: A Review of Unresolved Issues. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032585"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awr170","article-title":"A randomized placebo-controlled trial of idebenone in Leber\u2019s hereditary optic neuropathy","volume":"134","author":"Klopstock","year":"2011","journal-title":"Brain"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nut.2018.05.020","article-title":"Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization","volume":"57","author":"Navas","year":"2019","journal-title":"Nutrition"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ana.25506","article-title":"Deoxynucleoside Therapy for Thymidine Kinase 2-Deficient Myopathy","volume":"86","author":"Mavillard","year":"2019","journal-title":"Ann. Neurol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Bangeas, A., Poulidou, V., Liampas, I., Marogianni, C., Aloizou, A.-M., Tsouris, Z., Sgantzos, M., Arnaoutoglou, M., Bogdanos, D.P., and Dardiotis, E. (2025). Advances in Management of Mitochondrial Myopathies. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26115411"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Tung, C., Varzideh, F., Farroni, E., Mone, P., Kansakar, U., Jankauskas, S.S., and Santulli, G. (2025). Elamipretide: A Review of Its Structure, Mechanism of Action, and Therapeutic Potential. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26030944"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"101138","DOI":"10.1016\/j.gim.2024.101138","article-title":"Long-term efficacy and safety of elamipretide in patients with Barth syndrome: 168-week open-label extension results of TAZPOWER","volume":"26","author":"Thompson","year":"2024","journal-title":"Genet. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1212\/WNL.0000000000207402","article-title":"Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial","volume":"101","author":"Karaa","year":"2023","journal-title":"Neurology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1248\/bpb.b25-00218","article-title":"Mitochondrial Activation and Therapeutics: Innovations in Cell- and Organelle-Specific Medicine","volume":"48","author":"Sato","year":"2025","journal-title":"Biol. Pharm. Bull."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jacc.2020.12.060","article-title":"Mitochondria-Rich Extracellular Vesicles From Autologous Stem Cell\u2013Derived Cardiomyocytes Restore Energetics of Ischemic Myocardium","volume":"77","author":"Ikeda","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e23368","DOI":"10.1002\/advs.202523368","article-title":"Mitochondrial Transplantation as a Therapeutic Strategy for Inherited Mitochondrial Diseases","volume":"13","author":"Singh","year":"2026","journal-title":"Adv. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10616-025-00805-8","article-title":"Unlocking the potential of mitochondrial transplantation: Overcoming challenges and paving the way for routine therapeutic application","volume":"77","author":"Roushandeh","year":"2025","journal-title":"Cytotechnology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s42255-024-01200-x","article-title":"Recommendations for mitochondria transfer and transplantation nomenclature and characterization","volume":"7","author":"Brestoff","year":"2025","journal-title":"Nat. Metab."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7646\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:22:04Z","timestamp":1790932924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":56,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["jcm15197646"],"URL":"https:\/\/doi.org\/10.3390\/jcm15197646","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]}}}